Methotrexate and corticosteroids in the treatment of localized scleroderma: A standardized prospective longitudinal single-center study

Journal of Rheumatology

Volumn 39, Issue 2, 2012, Pages 286-294

  Torok, Kathryn S ^a   Arkachaisri, Thaschawee ^a,b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

Author keywords

Corticosteroids; Localized systemic sclerosis; Methotrexate; Pediatric rheumatic disease

Indexed keywords

CORTICOSTEROID; FOLIC ACID; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; TACROLIMUS; VITAMIN D DERIVATIVE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CUSHINGOID SYNDROME; DISEASE ACTIVITY; DISEASE DURATION; DISEASE EXACERBATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; ERYTHEMA; FEMALE; FOLLOW UP; HUMAN; HYPERTRANSAMINASEMIA; JUVENILE RHEUMATOID ARTHRITIS; LOCALIZED SCLERODERMA; LONGITUDINAL STUDY; MALE; MODIFIED LS SKIN SEVERITY INDEX; ONSET AGE; OUTCOME ASSESSMENT; PHYSICIAN GLOBAL ASSESSMENT OF DISEASE ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCLERITIS; THRUSH; TREATMENT DURATION;

CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METHOTREXATE; PREDNISONE; PROSPECTIVE STUDIES; SCLERODERMA, LOCALIZED; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84856557868     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110210     Document Type: Article

References (25)

1. Peterson LS, Nelson AM, Su WP, Mason T, O'Fallon WM, Gabriel SE. The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993. J Rheumatol 1997;24:73-80. (Pubitemid 27059861)
2. Sommer A, Gambichler T, Bacharach-Buhles M, von Rothenburg T, Altmeyer P, Kreuter A. Clinical and serological characteristics of progressive facial hemiatrophy: A case series of 12 patients. J Am Acad Dermatol 2006;54:227-33. (Pubitemid 43144391)
3. Zulian F, Athreya BH, Laxer R, Nelson AM, Feitosa de Oliveira SK, Punaro MG, et al. Juvenile localized scleroderma: Clinical and epidemiological features in 750 children. An international study. Rheumatology 2006;45:614-20.
4. Falanga V, Medsger TA Jr, Reichlin M, Rodnan GP. Linear scleroderma. Clinical spectrum, prognosis, and laboratory abnormalities. Ann Intern Med 1986;104:849-57. (Pubitemid 16115056)
5. Fitch PG, Rettig P, Burnham JM, Finkel TH, Yan AC, Akin E, et al. Treatment of pediatric localized scleroderma with methotrexate. J Rheumatol 2006;33:609-14. (Pubitemid 43334587)
6. Kreuter A, Gambichler T, Breuckmann F, Rotterdam S, Freitag M, Stuecker M, et al. Pulsed high-dose corticosteroids combined with low-dose methotrexate in severe localized scleroderma. Arch Dermatol 2005;141:847-52. (Pubitemid 41058065)
7. Seyger MM, van den Hoogen FH, de Boo T, de Jong EM. Low-dose methotrexate in the treatment of widespread morphea. J Am Acad Dermatol 1998;39(2 Pt 1):220-5. (Pubitemid 28367333)
8. Uziel Y, Feldman BM, Krafchik BR, Yeung RS, Laxer RM. Methotrexate and corticosteroid therapy for pediatric localized scleroderma. J Pediatr 2000;136:91-5. (Pubitemid 30468564)
9. Weibel L, Sampaio MC, Visentin MT, Howell KJ, Woo P, Harper JI. Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphoea) in children. Br J Dermatol 2006;155:1013-20. (Pubitemid 44564513)
10. Zulian F, Martini G, Vallongo C, Vittadello F, Falcini F, Patrizi A, et al. Methotrexate in juvenile localized scleroderma: A randomised, double-blind, placebo-controlled trial. Arthritis Rheum 2011;63:1998-2006.
11. Li SC, Feldman BM, Higgins GC, Haines KA, Punaro MG, O'Neil KM. Treatment of pediatric localized scleroderma: Results of a survey of North American pediatric rheumatologists. J Rheumatol 2010;37:175-81.
12. Arkachaisri T, Vilaiyuk S, Li S, O'Neil KM, Pope E, Higgins GC, et al. The localized scleroderma skin severity index and physician global assessment of disease activity: A work in progress toward development of localized scleroderma outcome measures. J Rheumatol 2009;36:2819-29.
13. Peterson LS, Nelson AM, Su WP. Classification of morphea (localized scleroderma). Mayo Clin Proc 1995;70:1068-76.
14. Joly P, Bamberger N, Crickx B, Belaich S. Treatment of severe forms of localized scleroderma with oral corticosteroids: follow-up study on 17 patients. Arch Dermatol 1994;130:663-4. (Pubitemid 24150954)
15. Cox D, O'Regan G, Collins S, Byrne A, Irvine A, Watson R. Juvenile localised scleroderma: A retrospective review of response to systemic treatment. Ir J Med Sci 2008;177:343-6.
16. van den Hoogen FH, Boerbooms AM, Swaak AJ, Rasker JJ, van Lier HJ, van de Putte LB. Comparison of methotrexate with placebo in the treatment of systemic sclerosis: A 24 week randomized double-blind trial, followed by a 24 week observational trial. Br J Rheumatol 1996;35:364-72.
17. Barrera P, Haagsma CJ, Boerbooms AM, van Riel PL, Borm GF, van de Putte LB, et al. Effect of methotrexate alone or in combination with sulphasalazine on the production and circulating concentrations of cytokines and their antagonists. Longitudinal evaluation in patients with rheumatoid arthritis. Br J Rheumatol 1995;34:747-55.
18. Rose CD, Fawcett PT, Gibney K, Doughty RA, Singsen BH. Serial measurements of soluble interleukin 2 receptor levels (sIL2-R) in children with juvenile rheumatoid arthritis treated with oral methotrexate. Ann Rheum Dis 1994;53:471-4. (Pubitemid 24252496)
19. Seitz M, Loetscher P, Dewald B, Towbin H, Rordorf C, Gallati H, et al. Methotrexate action in rheumatoid arthritis: Stimulation of cytokine inhibitor and inhibition of chemokine production by peripheral blood mononuclear cells. Br J Rheumatol 1995;34:602-9.
20. Ihn H, Sato S, Fujimoto M, Kikuchi K, Takehara K. Demonstration of interleukin 8 in serum samples of patients with localized scleroderma. Arch Dermatol 1994;130:1327-8. (Pubitemid 24313298)
21. Ihn H, Sato S, Fujimoto M, Kikuchi K, Takehara K. Demonstration of interleukin-2, interleukin-4 and interleukin-6 in sera from patients with localized scleroderma. Arch Dermatol Res 1995;287:193-7.
22. Uziel Y, Krafchik BR, Feldman B, Silverman ED, Rubin LA, Laxer RM. Serum levels of soluble interleukin-2 receptor. A marker of disease activity in localized scleroderma. Arthritis Rheum 1994;37:898-901. (Pubitemid 24184542)
23. Wallace CA. The use of methotrexate in childhood rheumatic diseases. Arthritis Rheum 1998;41:381-91. (Pubitemid 28128761)
24. Morrow GR, Rosenthal SN. Models, mechanisms and management of anticipatory nausea and emesis. Oncology 1996;53 Suppl 1:4-7. (Pubitemid 26335143)
25. Arkachaisri T, Pino S. Localized scleroderma severity index and global assessments: A pilot study of outcome instruments. J Rheumatol 2008;35:650-7. (Pubitemid 351500061)